<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00303407</url>
  </required_header>
  <id_info>
    <org_study_id>SPOT 99/54</org_study_id>
    <nct_id>NCT00303407</nct_id>
  </id_info>
  <brief_title>Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <brief_summary>
    <textblock>
      To determine the efficacy and to measure the complications of prophylactic anticoagulation
      using low-molecular weight heparin in adult cancer patients under palliative care
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>January 2001</start_date>
  <completion_date>July 2002</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <condition>Cancer</condition>
  <condition>Venous Thromboembolism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>nadroparin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cancer patients in palliative care

          -  Patients fully informed about their condition

          -  Signed informed consent

          -  No exclusion criteria

        Exclusion Criteria:

          -  Absence of advanced cancer

          -  Cancer previously cured

          -  Venous thromboembolism diagnosed within 6 months prior to inclusion

          -  Absence of discerning capacity

          -  Active anti-thrombotic treatment with heparins or coumarines

          -  Thrombocytopenia &lt;50G/l

          -  PTT &gt;45sec

          -  TP&lt;35%

          -  Active bleeding

          -  Renal failure &lt;20ml/min

          -  Past history of heparin-induced thrombocytopenia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Catherine Weber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center of Continuous Care, chemin de la Savonnière</name>
      <address>
        <city>Collonge-Bellerive (Geneva)</city>
        <state>Geneva</state>
        <zip>1245</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost. 1997 Jul;78(1):141-4. Review.</citation>
    <PMID>9198144</PMID>
  </reference>
  <verification_date>December 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2006</study_first_submitted>
  <study_first_submitted_qc>March 15, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2006</study_first_posted>
  <last_update_submitted>March 15, 2006</last_update_submitted>
  <last_update_submitted_qc>March 15, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nadroparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

